Wound Closure Devices - Medical Devices Pipeline Assessment, 2017

  • ID: 4429132
  • Report
  • 538 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • 3-D Matrix Ltd
  • C. R. Bard Inc
  • Dermtreat ApS
  • Innocoll Technologies Ltd
  • MLM Biologics Inc
  • Sheba Medical Center
  • MORE
Wound Closure Devices - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Wound Closure Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Wound Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Wound Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Wound Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Wound Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Wound Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3-D Matrix Ltd
  • C. R. Bard Inc
  • Dermtreat ApS
  • Innocoll Technologies Ltd
  • MLM Biologics Inc
  • Sheba Medical Center
  • MORE
1 Table of Contents
2 Introduction
2.1 Wound Closure Devices Overview
3 Products under Development
3.1 Wound Closure Devices - Pipeline Products by Stage of Development
3.2 Wound Closure Devices - Pipeline Products by Territory
3.3 Wound Closure Devices - Pipeline Products by Regulatory Path
3.4 Wound Closure Devices - Pipeline Products by Estimated Approval Date
3.5 Wound Closure Devices - Ongoing Clinical Trials
4 Wound Closure Devices - Pipeline Products under Development by Companies
4.1 Wound Closure Devices Companies - Pipeline Products by Stage of Development
4.2 Wound Closure Devices - Pipeline Products by Stage of Development
5 Wound Closure Devices Companies and Product Overview
5.1 3-D Matrix Ltd Company Overview
5.2 Actamax Surgical Materials LLC Company Overview
5.3 Adhesys Medical GmbH Company Overview
5.4 Advanced Medical Solutions Group plc Company Overview
5.5 Alafair Biosciences Inc Company Overview
5.6 Alumend LLC Company Overview
5.7 Anika Therapeutics Inc Company Overview
5.8 Arch Therapeutics Inc Company Overview
5.9 Argon Medical Devices Inc Company Overview
5.10 Aura Medsystems, Inc. Company Overview
5.11 Baxter International Inc Company Overview
5.12 Bayer HealthCare AG (Inactive) Company Overview
5.13 Bergen Medical Products Inc Company Overview
5.14 Beth Israel Deaconess Medical Center Inc Company Overview
5.15 Biomedica Management Corp Company Overview
5.16 Biom'Up SAS Company Overview
5.17 Boston University Company Overview
5.18 C. R. Bard Inc Company Overview
5.19 Calmare Therapeutics Inc Company Overview
5.20 CardioCommand Inc Company Overview
5.21 Cellphire Inc Company Overview
5.22 Ceramicos Para Aplicacoes Medicas Lda Company Overview
5.23 Clemson University Company Overview
5.24 Cohera Medical Inc Company Overview
5.25 Columbia University Company Overview
5.26 CorMedix Inc Company Overview
5.27 Covalent Medical, Inc. (Inactive) Company Overview
5.28 Covalon Technologies Ltd Company Overview
5.29 Cresilon Inc Company Overview
5.30 CryoLife Inc Company Overview
5.31 CSMG Technologies, Inc. (Inactive) Company Overview
5.32 Daewoong Pharmaceutical Co Ltd Company Overview
5.33 Dermtreat ApS Company Overview
5.34 DSM Biomedical BV Company Overview
5.35 Emory University Company Overview
5.36 Endomedix Incorporated Company Overview
5.37 Entegrion Inc Company Overview
5.38 Ethicon Endo-Surgery Inc Company Overview
5.39 Ethicon US LLC Company Overview
5.40 Gamma Therapeutics Inc Company Overview
5.41 Gecko Biomedical Company Overview
5.42 gel-e Inc Company Overview
5.43 Grifols SA Company Overview
5.44 Haemostatix Ltd Company Overview
5.45 Hemostasis LLC Company Overview
5.46 HyperBranch Medical Technology Inc Company Overview
5.47 Innocoll Technologies Ltd Company Overview
5.48 Institute of Molecular Biology of Parana Company Overview
5.49 Integra LifeSciences Holdings Corp Company Overview
5.50 InVivo Therapeutics Corp Company Overview
5.51 IonMed Ltd. Company Overview
5.52 John Hopkins University Company Overview
5.53 KeraNetics, LLC Company Overview
5.54 Kitotech Medical, Inc. Company Overview
5.55 Kollodis BioSciences Inc Company Overview
5.56 Kuros Biosciences AG Company Overview
5.57 Kytogenics Pharmaceuticals Inc Company Overview
5.58 Laser Tissue Welding, Inc. Company Overview
5.59 Latch Medical Ltd Company Overview
5.60 Lenvitz Medical Solutions Pvt. Ltd. Company Overview
5.61 Life Care Medical Devices Limited Company Overview
5.62 LifeBond Ltd Company Overview
5.63 Maxigen Biotech Inc Company Overview
5.64 Medisse BV (Inactive) Company Overview
5.65 Medtronic plc Company Overview
5.66 MLM Biologics Inc Company Overview
5.67 Northwestern University Company Overview
5.68 OptMed, Inc. Company Overview
5.69 PetVivo Holdings Inc Company Overview
5.70 Pharming Group NV Company Overview
5.71 Polyganics BV Company Overview
5.72 Protein Polymer Technologies Inc (Inactive) Company Overview
5.73 Regenics AS Company Overview
5.74 Resorba GmbH Company Overview
5.75 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
5.76 Rice University Company Overview
5.77 Samyang Biopharmaceuticals Corp Company Overview
5.78 Sanofi Company Overview
5.79 Sea Run Holdings Inc Company Overview
5.80 Sealantis Ltd. Company Overview
5.81 Seraffix Ltd Company Overview
5.82 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.83 Sheba Medical Center Company Overview
5.84 St Teresa Medical Inc Company Overview
5.85 Surgical Energetics LLC Company Overview
5.86 Surgical Sealants, Inc. Company Overview
5.87 Teijin Pharma Ltd Company Overview
5.88 Texas A&M University Company Overview
5.89 The Medicines Company Overview
5.90 ThermoTek, Inc. Company Overview
5.91 Therus Corporation Company Overview
5.92 Thrombotargets Corp Company Overview
5.93 Tribos LLC Company Overview
5.94 Tricol Biomedical Inc Company Overview
5.95 United Health Products, Inc. Company Overview
5.96 University of Akron Company Overview
5.97 University of Grenoble Alpes Company Overview
5.98 University of Kansas Company Overview
5.99 University of Toledo Company Overview
5.100 Vigor Medical Technologies Ltd. Company Overview
5.101 Virginia Commonwealth University Company Overview
5.102 Wound Management Technologies Inc Company Overview
5.103 WoundZipper Inc Company Overview
5.104 Xcede Technologies Inc Company Overview
6 Wound Closure Devices- Recent Developments
6.1 Sep 20, 2017: Actamax receives approval to begin pivotal clinical trial for Actamax Adhesion Barrier
6.2 Sep 19, 2017: Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update
6.3 Sep 19, 2017: Organogenesis Names New Chief Commercial Officer and Chief Operating Officer
6.4 Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates
6.5 Sep 13, 2017: Advanced Medical Solutions: Interim Results for the six months ended 30 June 2017
6.6 Sep 13, 2017: MiMedx Reiterates Its Third Quarter Revenue Expectation To Exceed $80 Million Despite Hurricane Irma
6.7 Sep 13, 2017: gel-e Expands Core Team with Regulatory, Manufacturing and Financial Talent
6.8 Sep 12, 2017: Arch Therapeutics Reports Favorable Results in Repeat Dose Testing of AC5 for Subchronic Systemic Toxicity
6.9 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director
6.10 Sep 11, 2017: Gecko Biomedical receives CE Mark Approval for SETALUM Sealant
6.11 Sep 07, 2017: St. Teresa Medical Announces First Commercial Use of SURGICLOT in Auckland, New Zealand
6.12 Sep 05, 2017: Polyganics Extends Global Distribution Network with the Addition of Multiple US Distributors
6.13 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery
6.14 Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs
6.15 Aug 24, 2017: Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN
6.16 Aug 23, 2017: Henry Ford Hospital CEO Announces Retirement
6.17 Aug 22, 2017: United Health Products Reports Second Quarter 2017 Results
6.18 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.19 Aug 21, 2017: WoundZipper Earns Patent for Magnetic Non-Suture Wound Closure Device
6.20 Aug 21, 2017: Covalon Releases Third Quarter Financial Results
6.21 Aug 15, 2017: Multiple Postmarket Clinical Studies Nearing Completion in Europe, Supporting Broad Range of Applications for TissuGlu Surgical Adhesive
6.22 Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results
6.23 Aug 09, 2017: The Medicines Company Reports Second Quarter 2017 Business and Financial Results
6.24 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker
6.25 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance
6.26 Aug 02, 2017: United Health Products Reports Profitable First Quarter ended March 31, 2017
6.27 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd
6.28 Aug 01, 2017: Owens & Minor Reports 2nd Quarter 2017 Financial Results
6.29 Jul 31, 2017: Advanced Medical Solutions Group Reports H1 2016 Results
6.30 Jul 31, 2017: Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER
6.31 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen
6.32 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions
6.33 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang
6.34 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results
6.35 Jul 27, 2017: Stryker reports second quarter 2017 results
6.36 Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President
6.37 Jul 27, 2017: JustRight Surgical Announces New CEO
6.38 Jul 26, 2017: MiMedx Announces Record Results For The Second Quarter Of 2017 And Raises Full Year Revenue Guidance
6.39 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020
6.40 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results
6.41 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance
6.42 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results
6.43 Jul 25, 2017: Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5 Topical Gel
6.44 Jul 24, 2017: Ergomed completes Phase IIb study recruitment six months ahead of schedule for its innovative coagulant PeproStat
6.45 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results
6.46 Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter
6.47 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results
6.48 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board
6.49 Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range
6.50 Jul 12, 2017: TissuGlu Surgical Adhesive facilitates drain-free mastectomy
6.51 Jul 12, 2017: Sanofi: Pre-quarterly Results Communication
6.52 Jul 10, 2017: InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer
6.53 Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down
6.54 Jul 05, 2017: Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies
6.55 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Wound Closure Devices - Pipeline Products by Stage of Development
Table 2: Wound Closure Devices - Pipeline Products by Territory
Table 3: Wound Closure Devices - Pipeline Products by Regulatory Path
Table 4: Wound Closure Devices - Pipeline Products by Estimated Approval Date
Table 5: Wound Closure Devices - Ongoing Clinical Trials
Table 7: Wound Closure Devices Companies - Pipeline Products by Stage of Development
Table 8: Wound Closure Devices - Pipeline Products by Stage of Development
Table 9: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 10: PuraStat Hemostat - Product Status
Table 11: PuraStat Hemostat - Product Description
Table 12: TDM-511 - Product Status
Table 13: TDM-511 - Product Description
Table 14: 3-D Matrix Ltd - Ongoing Clinical Trials Overview
Table 15: PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery
Table 16: PuraStat Hemostat - Randomized Controlled Trial Comparing Purastat to Standard Therapy for Haemostasis Control During Endoscopic Submucosal Dissection
Table 17: Actamax Surgical Materials LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Actamax Adhesion Barrier - Product Status
Table 19: Actamax Adhesion Barrier - Product Description
Table 20: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 21: CUTIS - Product Status
Table 22: CUTIS - Product Description
Table 23: Tissue Adhesive - Pancreatectomy - Product Status
Table 24: Tissue Adhesive - Pancreatectomy - Product Description
Table 25: VIVO - Product Status
Table 26: VIVO - Product Description
Table 27: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: LiquiBand - Product Status
Table 29: LiquiBand - Product Description
Table 30: LiquiBand Exceed - Product Status
Table 31: LiquiBand Exceed - Product Description
Table 32: LiquiBand Flow Control - Product Status
Table 33: LiquiBand Flow Control - Product Description
Table 34: Next Generation Internal Fixation And Sealant Device - Product Status
Table 35: Next Generation Internal Fixation And Sealant Device - Product Description
Table 36: Advanced Medical Solutions Group plc - Ongoing Clinical Trials Overview
Table 37: LiquiBand Exceed - Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast Surgery
Table 38: Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: VersaWrap Adhesion Barrier - Product Status
Table 40: VersaWrap Adhesion Barrier - Product Description
Table 41: Alumend LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Tissue-Bonding Adhesive - Product Status
Table 43: Tissue-Bonding Adhesive - Product Description
Table 44: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Hemostatic Patch - Product Status
Table 46: Hemostatic Patch - Product Description
Table 47: Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: AC5 Surgical Hemostatic Device - Product Status
Table 49: AC5 Surgical Hemostatic Device - Product Description
Table 50: AC5 Surgical Hemostatic Device - Internal Use - Product Status
Table 51: AC5 Surgical Hemostatic Device - Internal Use - Product Description
Table 52: Argon Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Hemaseel HMN Fibrin Sealant - Product Status
Table 54: Hemaseel HMN Fibrin Sealant - Product Description
Table 55: Hemaseel Thrombin Haemostatic Agent - Product Status
Table 56: Hemaseel Thrombin Haemostatic Agent - Product Description
Table 57: Aura Medsystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 58: LaSTR - Skin Closure Device - Product Status
Table 59: LaSTR - Skin Closure Device - Product Description
Table 60: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Hemopatch - Product Status
Table 62: Hemopatch - Product Description
Table 63: Tisseel Dura - Product Status
Table 64: Tisseel Dura - Product Description
Table 65: Baxter International Inc - Ongoing Clinical Trials Overview
Table 66: Hemopatch - A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (more than 5 Days - PAL)
Table 67: Hemopatch - A Prospective Randomized Trial of Hemopatch Versus No Hemopatch for the Intraoperative Hemostasis During Deceased Donor Renal Transplant
Table 68: Hemopatch - Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the use of the New Hemostatic Patch Hemopatch in Patients undergoing Surgical Liver Resection
Table 69: Hemopatch - Prospective Randomized Clinical Trial to Prevent Air Leaks After Lung Resection with Hemopatch Sealing Hemostat: SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial
Table 70: Hemopatch - Prospective, Multicenter, Open-label, Randomized, Phase III Clinical Trial of Prevention of Prolonged Air Leak after Lung Resection in High-risk Patients, Applying HEMOPATCH
Table 71: Bayer HealthCare AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Polyurethane Adhesive System - Product Status
Table 73: Polyurethane Adhesive System - Product Description
Table 74: Bergen Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 75: ACTACLOSE - Product Status
Table 76: ACTACLOSE - Product Description
Table 77: Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Portable Wound Hemostasis System - Product Status
Table 79: Portable Wound Hemostasis System - Product Description
Table 80: Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 81: ClotBlock - Product Status
Table 82: ClotBlock - Product Description
Table 83: ClotFoam - Product Status
Table 84: ClotFoam - Product Description
Table 85: ClotGel - Product Status
Table 86: ClotGel - Product Description
Table 87: ClotSpray - Product Status
Table 88: ClotSpray - Product Description
Table 89: Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Hemoblast Bellows - Product Status
Table 91: Hemoblast Bellows - Product Description
Table 92: Biom'Up SAS - Ongoing Clinical Trials Overview
Table 93: Hemoblast Bellows - Prospective, Randomized, Controlled, Multicenter, Pivotal, Clinical Investigation Evaluating the Safety and Efficacy of Hemoblast Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries
Table 94: Boston University Pipeline Products & Ongoing Clinical Trials Overview
Table 95: Hydrogel-based Aerosolized Sealant Dressing - Product Status
Table 96: Hydrogel-based Aerosolized Sealant Dressing - Product Description
Table 97: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 98: New Hemostat 1 - Product Status
Table 99: New Hemostat 1 - Product Description
Table 100: New Hemostat 2 - Product Status
Table 101: New Hemostat 2 - Product Description
Table 102: Progel Dural Sealant - Product Status
Table 103: Progel Dural Sealant - Product Description
Table 104: Progel Emerald - Product Status
Table 105: Progel Emerald - Product Description
Table 106: ProGEL-VS - Product Status
Table 107: ProGEL-VS - Product Description
Table 108: Tridyne Peripheral - Product Status
Table 109: Tridyne Peripheral - Product Description
Table 110: Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 111: Wound Sealant - Product Status
Table 112: Wound Sealant - Product Description
Table 113: CardioCommand Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 114: Tournicath Device - Product Status
Table 115: Tournicath Device - Product Description
Table 116: Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 117: Thromboderm - Product Status
Table 118: Thromboderm - Product Description
Table 119: Thrombosomes - Hemostatic Agent - Product Status
Table 120: Thrombosomes - Hemostatic Agent - Product Description
Table 121: Ceramicos Para Aplicacoes Medicas Lda Pipeline Products & Ongoing Clinical Trials Overview
Table 122: HemoKi - Product Status
Table 123: HemoKi - Product Description
Table 124: Clemson University Pipeline Products & Ongoing Clinical Trials Overview
Table 125: Surgical Adhesive Hydrogel - Product Status
Table 126: Surgical Adhesive Hydrogel - Product Description
Table 127: Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 128: Sylys Surgical Sealant - Product Status
Table 129: Sylys Surgical Sealant - Product Description
Table 130: Sylys Surgical Sealant - Drug Delivery - Product Status
Table 131: Sylys Surgical Sealant - Drug Delivery - Product Description
Table 132: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Status
Table 133: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Description
Table 134: Sylys Surgical Sealant - Orthopedic Procedures - Product Status
Table 135: Sylys Surgical Sealant - Orthopedic Procedures - Product Description
Table 136: Cohera Medical Inc - Ongoing Clinical Trials Overview
Table 137: Sylys Surgical Sealant - A Pilot, Prospective, Randomized, Controlled, Multicenter Technical Feasibility Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys Surgical Sealant
Table 138: Sylys Surgical Sealant - A Pivotal, Prospective, Randomized, Controlled, Multi-center Superiority Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Technique Plus Sylys Surgical Sealant
Table 139: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 140: Hemostatic Wound Dressing - Product Status
Table 141: Hemostatic Wound Dressing - Product Description
Table 142: CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 143: Taurolidine Wound Closures - Product Status
Table 144: Taurolidine Wound Closures - Product Description
Table 145: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 146: Covabond - Product Status
Table 147: Covabond - Product Description
Table 148: CovaSTAT - Product Status
Table 149: CovaSTAT - Product Description
Table 150: Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Wound Closure Devices - Pipeline Products by Stage of Development
Figure 2: Wound Closure Devices - Pipeline Products by Territory
Figure 3: Wound Closure Devices - Pipeline Products by Regulatory Path
Figure 4: Wound Closure Devices - Pipeline Products by Estimated Approval Date
Figure 5: Wound Closure Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3-D Matrix Ltd
  • Actamax Surgical Materials LLC
  • Adhesys Medical GmbH
  • Advanced Medical Solutions Group plc
  • Alafair Biosciences Inc
  • Alumend LLC
  • Anika Therapeutics Inc
  • Arch Therapeutics Inc
  • Argon Medical Devices Inc
  • Aura Medsystems, Inc.
  • Baxter International Inc
  • Bayer HealthCare AG
  • Bergen Medical Products Inc
  • Beth Israel Deaconess Medical Center Inc
  • Biomedica Management Corp
  • Biom'Up SAS
  • Boston University
  • C. R. Bard Inc
  • Calmare Therapeutics Inc
  • CardioCommand Inc
  • Cellphire Inc
  • Ceramicos Para Aplicacoes Medicas Lda
  • Clemson University
  • Cohera Medical Inc
  • Columbia University
  • CorMedix Inc
  • Covalent Medical, Inc.
  • Covalon Technologies Ltd
  • Cresilon Inc
  • CryoLife Inc
  • CSMG Technologies, Inc.
  • Daewoong Pharmaceutical Co Ltd
  • Dermtreat ApS
  • DSM Biomedical BV
  • Emory University
  • Endomedix Incorporated
  • Entegrion Inc
  • Ethicon Endo-Surgery Inc
  • Ethicon US LLC
  • Gamma Therapeutics Inc
  • Gecko Biomedical
  • gel-e Inc
  • Grifols SA
  • Haemostatix Ltd
  • Hemostasis LLC
  • HyperBranch Medical Technology Inc
  • Innocoll Technologies Ltd
  • Institute of Molecular Biology of Parana
  • Integra LifeSciences Holdings Corp
  • InVivo Therapeutics Corp
  • IonMed Ltd.
  • John Hopkins University
  • KeraNetics, LLC
  • Kitotech Medical, Inc.
  • Kollodis BioSciences Inc
  • Kuros Biosciences AG
  • Kytogenics Pharmaceuticals Inc
  • Laser Tissue Welding, Inc.
  • Latch Medical Ltd
  • Lenvitz Medical Solutions Pvt. Ltd.
  • Life Care Medical Devices Limited
  • LifeBond Ltd
  • Maxigen Biotech Inc
  • Medisse BV
  • Medtronic plc
  • MLM Biologics Inc
  • Northwestern University
  • OptMed, Inc.
  • PetVivo Holdings Inc
  • Pharming Group NV
  • Polyganics BV
  • Protein Polymer Technologies Inc
  • Regenics AS
  • Resorba GmbH
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • Rice University
  • Samyang Biopharmaceuticals Corp
  • Sanofi
  • Sea Run Holdings Inc
  • Sealantis Ltd.
  • Seraffix Ltd
  • Shanghai Haohai Biological Technology Co Ltd
  • Sheba Medical Center
  • St Teresa Medical Inc
  • Surgical Energetics LLC
  • Surgical Sealants, Inc.
  • Teijin Pharma Ltd
  • Texas A&M University
  • The Medicines Company
  • ThermoTek, Inc.
  • Therus Corporation
  • Thrombotargets Corp
  • Tribos LLC
  • Tricol Biomedical Inc
  • United Health Products, Inc.
  • University of Akron
  • University of Grenoble Alpes
  • University of Kansas
  • University of Toledo
  • Vigor Medical Technologies Ltd.
  • Virginia Commonwealth University
  • Wound Management Technologies Inc
  • WoundZipper Inc
  • Xcede Technologies Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll